UTHealth's Rex Marco, M.D., honored by sarcoma cancer foundation

December 13, 2013

Rex Marco, M.D., professor in the Department of Orthopaedic Surgery at The University of Texas Health Science Center at Houston (UTHealth) Medical School, is the recipient of an award recognizing excellence in the treatment of a type of cancer called sarcoma.

Marco was presented the Commitment to Care Award by The Amschwand Sarcoma Cancer Foundation (ASCF) on Nov. 7 at its annual gala in Houston.

It was Tom Amschwand's vision to create a nonprofit organization dedicated to funding sarcoma research, to raising awareness and to providing tangible support to families affected by the disease. Amschwand lost his battle with sarcoma in February of 2001 - the same month ASCF was founded.

Since then, his widow, Melissa Amschwand-Bellinger, has committed herself to carrying out the foundation's mission, which includes providing nearly 1,000 nights of free housing for patients coming to Houston for care each year. Marco provides care for many of those patients.

"Dr. Marco was selected for the care and compassion that he offers to his patients. He knows what it's like to be on the other side of the doctor-patient relationship. Dr. Marco lost his father to cancer. He truly treats his patients like they are family," Amschwand-Bellinger said.

Marco's patients include Rhonda Johnson who has been cancer-free for 3 ½ years. "I was in pretty bad shape when I first met Dr. Marco. He helped save my life," Johnson said.

Johnson said Marco is extremely attuned to the needs of his patients and cited her survival color - red - as an example. "Red was my energy color, positive energy. Red helps me stay positive so I had red blankets and red clothes. Even the chemotherapy was red. I called that positive red energy chemo," she said.

Consequently, it was not lost on Johnson when Marco showed up in surgery wearing red scrubs. "I can't tell you what type of impression that made on me," she said.

Marco specializes in the care of tumors affecting muscle or bone and employs a combination of surgery, medication and radiation. He is the chief of spine surgery and muscloskeletal oncology at the UTHealth Medical School.

Practicing medicine for about 15 years, Marco is recognized worldwide for his expertise and training in the care of complex spinal disorders and muscloskeletal tumors.

Marco completed his pre-med studies at the University of California, Irvine, finished a research fellowship at the Howard Hughes Medical Institute and received his medical degree from the University of California, Los Angeles.
-end-
Patient appointments with Marco can be scheduled by calling 713-838-8300.

University of Texas Health Science Center at Houston

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.